The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
92603065 9260306 5 F 20120412 20160831 20130429 20160908 EXP PHHY2013JP042095 NOVARTIS 34.30 YR M Y 83.00000 KG 20160908 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
92603065 9260306 1 PS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD 80 MG 22334 10 MG TABLET QD
92603065 9260306 2 SS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD 80 MG 22334 10 MG TABLET QD
92603065 9260306 3 SS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD 80 MG 22334 10 MG TABLET QD
92603065 9260306 4 SS AFINITOR EVEROLIMUS 1 Oral 10 MG, UNK 80 MG 22334 10 MG TABLET
92603065 9260306 5 SS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD 80 MG 22334 10 MG TABLET QD
92603065 9260306 6 C SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 20 UG, UNK U 0 20 UG
92603065 9260306 7 C TEGRETOL CARBAMAZEPINE 1 Oral 1000 MG, UNK U 0 1000 MG
92603065 9260306 8 C ALEVIATIN PHENYTOIN SODIUM 1 Oral 400 MG, UNK U 0 400 MG
92603065 9260306 9 C DEPAKENE VALPROIC ACID 1 Oral 600 MG, UNK U 0 600 MG
92603065 9260306 10 C LOXOPROFEN LOXOPROFEN 1 Oral 60 MG, UNK U 0 60 MG
92603065 9260306 11 C AZUNOL SODIUM GUALENATE 1 Oral U 0
92603065 9260306 12 C DEXALTIN DEXAMETHASONE 1 Oral U 0
92603065 9260306 13 C LOCHOL FLUVASTATIN SODIUM 1 Unknown U 0
92603065 9260306 14 C LANTUS INSULIN GLARGINE 1 Unknown U 0
92603065 9260306 15 C NOVORAPID INSULIN ASPART 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
92603065 9260306 1 Pancreatic neuroendocrine tumour
92603065 9260306 6 Pancreatic neuroendocrine tumour
92603065 9260306 7 Epilepsy
92603065 9260306 8 Product used for unknown indication
92603065 9260306 9 Product used for unknown indication
92603065 9260306 10 Product used for unknown indication
92603065 9260306 11 Product used for unknown indication
92603065 9260306 12 Product used for unknown indication
92603065 9260306 13 Product used for unknown indication
92603065 9260306 14 Product used for unknown indication
92603065 9260306 15 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
92603065 9260306 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
92603065 9260306 Gamma-glutamyltransferase increased
92603065 9260306 Hypercholesterolaemia
92603065 9260306 Hyperglycaemia
92603065 9260306 Hypertriglyceridaemia
92603065 9260306 Nasopharyngitis
92603065 9260306 Pruritus
92603065 9260306 Pyrexia
92603065 9260306 Rash
92603065 9260306 Stomatitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
92603065 9260306 1 20111103 0
92603065 9260306 2 20120405 20120420 0
92603065 9260306 3 20120424 20121031 0
92603065 9260306 6 20120405 0
92603065 9260306 10 20120420 0